Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | April 4, 2014 |
| Target | Cedarburg Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Curia |
| Deal Type | Add-on Acquisition |
| Deal Value | 41M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1991 |
| Sector | Life Science |
| Employees | 2,220 |
| Revenue | 402M USD (2015) |
Curia is a contract development and manufacturing organization (CDMO) providing services from drug discovery through development and manufacturing for small molecules, generic APIs, and biologics. The company draws on many years of experience and operates globally with integrated facilities in North America, Europe, and Asia. Curia was founded in 1991 and is headquartered in Albany, New York.
| Deal Context for Buyer | # |
|---|---|
| Overall | 3 of 11 |
| Sector: Life Science | 2 of 9 |
| Type: Add-on Acquisition | 3 of 8 |
| State: Wisconsin | 1 of 1 |
| Country: United States | 2 of 7 |
| Year: 2014 | 1 of 2 |
| Size (of disclosed) | 6 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-06-14 |
Hyaluron
Burlington, Massachusetts, United States Hyaluron provides these services for both small molecule drug products as well as biologicals, from clinical phase to commercial scale. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-06-02 |
OSO BioPharmaceuticals Manufacturing
Albuquerque, New Mexico, United States OsoBio is a leading contract manufacturer of injectable pharmaceutical products. The company provides glass vial filling and lyophilization services for drugs and biologics that are either approved for commercial marketing or in clinical development. With facilities equipped to handle highly potent and toxic active pharmaceutical ingredients, OsoBio focuses on the production of products that require special or complex handling. |
Buy | $110M |
